← Leaderboards
Fredrick M Wigley
Johns Hopkins University
$3,308,667
Attributed
$3,308,667
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $437.4K · FY2007–16$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,308,667 · 4
By mechanism
P50$2,112,343 · 1
T32$1,115,545 · 1
M01$80,779 · 2
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Harry C. Dietz$10,377,475
- Antony Rosen$15,771,548
- Livia A Casciola-Rosen$11,279,825
- David R Moller$5,759,968
- Terry J Watnick$15,139,236
Others in their field
Top investigators on “Scleroderma”
- Eugene W. St Clair · Duke University$24,182,181
- John Varga · University Of Illinois At Chicago$15,372,802
- Maria Trojanowska · Boston University Medical Campus$15,165,208
- Roger A Johns · Johns Hopkins University$12,479,815
- Carol A Feghali-Bostwick · University Of Pittsburgh At Pittsburgh$12,032,767
- Judith A James · Oklahoma Medical Research Foundation$11,331,322
Research focus
SclerodermaSystemic SclerodermaCytotoxicAngiogenic FactorCytoplasmic GranulesAutoantibodiesAngiogenesisBlood VesselsAutoimmunityAutomobile DrivingCor PulmonaleAngiostatinsBlood CirculationBlood SpecimenAutoantigensAntibodiesBlood VolumeAutoimmune ProcessCellsCessation Of LifeCleaved CellClinical PhenotypeAttentionCohort
Grant awards (13)
Multidisciplinary Rheumatology Training Program$292,175
T32 · FY2016 · AR · contact PI
Multidisciplinary Rheumatology Training Program$256,767
T32 · FY2015 · AR · contact PI
Multidisciplinary Rheumatology Training Program$292,903
T32 · FY2014 · AR · contact PI
Multidisciplinary Rheumatology Training Program$273,700
T32 · FY2013 · AR · contact PI
DYSREGULATED ANGIOGENESIS IN SCLERODERMA-ASSOCIATED PAH$437,370
P50 · FY2011 · HL · contact PI
DYSREGULATED ANGIOGENESIS IN SCLERODERMA-ASSOCIATED PAH$435,049
P50 · FY2010 · HL · contact PI
DYSREGULATED ANGIOGENESIS IN SCLERODERMA-ASSOCIATED PAH$426,575
P50 · FY2009 · HL · contact PI
DYSREGULATED ANGIOGENESIS IN SCLERODERMA-ASSOCIATED PAH$416,957
P50 · FY2008 · HL · contact PI
DYSREGULATED ANGIOGENESIS IN SCLERODERMA-ASSOCIATED PAH$396,392
P50 · FY2007 · HL · contact PI
Novel Biomarkers of Pulmonary Hypertension in Scleroderma$15,610
M01 · FY2004 · RR
ZINC THERAPY FOR SCLERODERMA--PHASE I STUDY$0
M01 · FY2002 · RR
ZINC THERAPY FOR SCLERODERMA--PHASE I STUDY$0
M01 · FY2001 · RR
ZINC THERAPY FOR SCLERODERMA--PHASE I STUDY$65,169
M01 · FY2000 · RR